K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Roy Jones
also known as JONES, Roy, Jones, R, Jones, Roy
The Research Institute for the Care of Older People · University of Bath · Oklahoma State University · Louisiana State University
About this author
Works
413
Cited by
16,439
h-index
64
i10
199
ORCID ↗
Top papers
Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes, Delphine Boche, David Wilkinson, et al.
·
2008
·
The Lancet
↗ 1,388
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard, Rupert McShane, James Lindesay, et al.
·
2012
·
New England Journal of Medicine
↗ 760
OA
On the path to 2025: understanding the Alzheimer’s disease continuum
Paul Aisen, Jeffrey L. Cummings, Clifford R. Jack, et al.
·
2017
·
Alzheimer s Research & Therapy
↗ 548
OA
Coherent concepts are computed in the anterior temporal lobes
Matthew A. Lambon Ralph, Karen Sage, Roy Jones, et al.
·
2010
·
Proceedings of the National Academy of Sciences
↗ 494
OA
Drug development in Alzheimer’s disease: the path to 2025
Jeffrey L. Cummings, Paul Aisen, Bruno Dubois, et al.
·
2016
·
Alzheimer s Research & Therapy
↗ 450
OA
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
Howard Feldman, Rachelle S. Doody, Miia Kivipelto, et al.
·
2010
·
Neurology
↗ 432
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Murat Emre, Magda Tsolaki, Ubaldo Bonuccelli, et al.
·
2010
·
The Lancet Neurology
↗ 430
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
Lucy Webster, Derek Groskreutz, Anna Grinbergs‐Saull, et al.
·
2017
·
PLoS ONE
↗ 413
OA
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
John T. O’Brien, Clive Holmes, Matthew S. Jones, et al.
·
2017
·
Journal of Psychopharmacology
↗ 353
OA
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
Antony Bayer, R. Morris Bullock, Roy Jones, et al.
·
2005
·
Neurology
↗ 350
Donepezil for the Treatment of Agitation in Alzheimer's Disease
Robert Howard, Edmund Juszczak, Clive Ballard, et al.
·
2007
·
New England Journal of Medicine
↗ 325
OA
Comprehension of concrete and abstract words in semantic dementia.
Elizabeth Jefferies, Karalyn Patterson, Roy Jones, et al.
·
2009
·
Neuropsychology
↗ 251
OA